A carregar...
Acute myeloid leukemia targets for bispecific antibodies
Despite substantial gains in our understanding of the genomics of acute myelogenous leukemia (AML), patient survival remains unsatisfactory especially among the older age group. T cell-based therapy of lymphoblastic leukemia is rapidly advancing; however, its application in AML is still lagging behi...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386336/ https://ncbi.nlm.nih.gov/pubmed/28157217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|